Bg pattern

ALDOBRONQUIAL 2 mg/5 ml SYRUP

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use ALDOBRONQUIAL 2 mg/5 ml SYRUP

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Leaflet:information for theuser

ALDOBRONQUIAL 2mg/5 mlsyrup

Salbutamol (sulfate)

Read the entire leaflet carefully before startingto takethis medication, as it contains important information for you.

  • Keep this leaflet, as you may need to read it again. If you have any questions, consult your doctor, pharmacist, or nurse.
  • This medication has been prescribed to you only, and you should not give it to others, even if they have the same symptoms as you, as it may harm them.
  • If you experience side effects, consult your doctor, pharmacist, or nurse, even if they are not listed in this leaflet. See section 4.

Contents of the leaflet

  1. What is ALDOBRONQUIAL 2mg/5 ml syrup and what is it used for
  2. What you need to know before starting to take ALDOBRONQUIAL 2mg/5 ml syrup
  3. How to take ALDOBRONQUIAL 2mg/5 ml syrup
  4. Possible side effects
  5. Storage of ALDOBRONQUIAL 2mg/5 ml syrup
  6. Package contents and additional information

1. What is ALDOBRONQUIAL 2mg/5 ml syrup and what is it used for

ALDOBRONQUIAL syrup contains salbutamol as the active ingredient. It belongs to a group of medications called bronchodilators.

ALDOBRONQUIAL syrup is indicated for the prevention and symptomatic treatment of bronchial spasm (closure of airways in the lungs) associated with asthma attacks and in processes associated with reversible obstruction of the airways. These are a group of lung diseases that cause inflammation of the airways, resulting in a blockage of airflow in the lungs.

.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before starting to take ALDOBRONQUIAL 2mg/5 ml syrup

Do not take ALDOBRONQUIAL syrup

  • if you are allergic to salbutamol or any of the other components of this medication (listed in section 6).

Warnings and precautions

Consult your doctor, pharmacist, or nurse before starting to take ALDOBRONQUIAL syrup:

  • If you have a thyroid disease (hyperthyroidism)
  • If you have a history of heart disease, irregular heartbeat, or angina pectoris
  • If you have high blood pressure (hypertension)
  • If you have acute asthma. This medication may cause a decrease in potassium levels, which could be increased by hypoxia (low oxygen)
  • The decrease in potassium levels caused by this medication could be increased by other medications used to treat asthma
  • If you are diabetic. This medication may increase blood glucose levels

Children and adolescents

The efficacy and safety of ALDOBRONQUIAL syrup have not been adequately demonstrated in children under 2 years of age.

Use in athletes

This medication contains salbutamol, which may produce a positive result in doping tests.

Taking ALDOBRONQUIAL syrup with other medications

Inform your doctor or pharmacist if you are taking, have recently taken, or may need to take any other medication.

Do not administer concurrently with non-cardioselective beta-blockers, such as propranolol or similar medications. Non-cardioselective beta-blockers are used to treat high blood pressure (hypertension), abnormal heart rhythm (arrhythmia), chest pain (angina pectoris), to prevent migraines, and topically to treat glaucoma. Beta-blockers are sometimes administered to patients who have suffered a heart attack to prevent further attacks.

Pregnancy, breastfeeding, and fertility

If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medication.

It should only be used during pregnancy or breastfeeding if the potential benefit clearly outweighs the potential risk.

Driving and using machines

The influence of ALDOBRONQUIAL syrup on the ability to drive and use machines is negligible or insignificant.

3. How to take ALDOBRONQUIAL 2mg/5 ml syrup

Follow the administration instructions for this medication exactly as indicated by your doctor. If you are unsure, consult your doctor or pharmacist again.

Remember to take your medication.

Your doctor will indicate the duration of your treatment with ALDOBRONQUIAL syrup. Do not stop treatment before then.

If your doctor has diluted your ALDOBRONQUIAL syrup, the resulting mixture should be protected from light and used within 28 days.

Adults

The recommended dose is 5 ml to 10 ml (2 to 4 mg) administered three or four times a day.

Use in children and adolescents

Two to six years: the recommended dose is 2.5 ml to 5 ml (1 to 2 mg) three or four times a day.

Six to twelve years: the recommended dose is 5 ml (2 mg) three or four times a day.

Over twelve years: the recommended dose is 5 ml to 10 ml (2 to 4 mg) administered three or four times a day.

Your doctor may have prescribed a higher dose than recommended above.

ALDOBRONQUIAL syrup is suitable for adults and children who prefer to take liquid medications.

For children, elderly people, and those with marked sensitivity to this medication, it is recommended to start treatment with 5 ml of ALDOBRONQUIAL syrup (2 mg) three or four times a day.

IT IS VERY IMPORTANT that you follow the administration instructions for this medication exactly as contained in this leaflet or as indicated by your doctor regarding the amount you should take and how often. DO NOT TAKE more than indicated. If you are unsure, ask your doctor.

If you think the effect of ALDOBRONQUIAL syrup is too strong or too weak, inform your doctor or pharmacist AS SOON AS POSSIBLE. Your asthma may start to worsen, and you may need another type of medication.

If you take more ALDOBRONQUIAL syrup than you should

In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone 91 562 04 20, indicating the medication and the amount ingested.

However, if the amount ingested is significant, you should go to the doctor immediately or to the emergency department of the nearest hospital. It is recommended to bring the packaging and leaflet of the medication to the healthcare professional.

If you accidentally take a higher dose than recommended, you are more likely to experience side effects such as increased heart rate, headaches, tremors, or muscle cramps (see Possible side effects). You should inform your doctor as soon as possible if the dose you have taken is higher than recommended.

If you forget to take ALDOBRONQUIAL syrup

Do not take a double dose to make up for forgotten doses. If you forget to take a dose, take another as soon as you remember, but if it is almost time for your next dose, wait until then.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible side effects

Like all medications, ALDOBRONQUIAL syrup can cause side effects, although not everyone will experience them.

The following side effects are associated with salbutamol, classified by organ, system, and frequency. The frequencies have been defined as follows: very common (affect 1 or more out of 10 people), common (affect 1 to 10 out of 100 people), uncommon (affect 1 to 10 out of 1000 people), rare (affect 1 to 10 out of 10,000 people), and very rare (affect less than 1 out of 10,000 people), including isolated reports. The very common, common, and uncommon side effects have been identified from clinical trial data. The rare and very rare events come from spontaneous reports.

Immune system disorders

Very rare: Hypersensitivity reactions (allergic reactions) including angioedema (skin reactions with redness, swelling, and itching), urticaria, bronchospasm (narrowing of the bronchial walls with decreased air intake), hypotension, and collapse.

Metabolic and nutritional disorders

Rare: Hypokalemia (low potassium levels in the blood).

Therapy with beta-2 agonists may lead to potentially severe hypokalemia.

Nervous system disorders

Very common: Tremor

Common: Headaches.

Very rare: Hyperactivity.

Cardiac disorders

Common: Tachycardia (increased heart rate), palpitations.

Rare: Cardiac arrhythmias, including atrial fibrillation, supraventricular tachycardia, and extrasystoles (heart rhythm disorders).

Unknown: Myocardial ischemia* (see section 2).

Although the exact frequency is unknown, some people may occasionally experience chest pain (due to heart problems such as angina pectoris). Inform your doctor if you develop these symptoms while being treated with ALDOBRONQUIAL syrup, but do not stop taking this medication unless your doctor indicates so.

*Spontaneous reports of post-marketing data, so the frequency is classified as unknown.

Vascular disorders

Rare: Peripheral vasodilation (dilation of peripheral blood vessels).

Musculoskeletal and connective tissue disorders

Common: Muscle cramps

Very rare: Muscle tension sensation

If you experience side effects, consult your doctor, pharmacist, or nurse, even if they are not listed in this leaflet.

5. Storage of ALDOBRONQUIAL 2mg/5 ml syrup

Keep this medication out of sight and reach of children.

No special storage conditions are required.

Expiry date

Do not use this medication after the expiry date stated on the bottle after EXP. The expiry date is the last day of the month indicated.

Medications should not be disposed of through wastewater or household waste. Deposit the packaging and medications you no longer need at the SIGRE collection point in your pharmacy. If you are unsure, ask your pharmacist how to dispose of the packaging and medications you no longer need. This will help protect the environment.

6. ADDITIONAL INFORMATION

Composition of ALDOBRONQUIAL 2mg/5 ml syrup

  • The active ingredient is salbutamol (sulfate). Each 5 ml contains 2 mg of salbutamol (sulfate).
  • The other components (excipients) are: sodium benzoate (E-211), hypromellose, sodium saccharin, citric acid, sodium citrate, orange flavor, and purified water.

Appearance of the product and package contents

ALDOBRONQUIAL syrup is a colorless and transparent liquid with an orange odor, presented in a 100 ml bottle with a dosing cup.

Marketing authorization holder and manufacturer

Laboratorio ALDO-UNIÓN, S.L.

Baronesa de Maldà, 73

08950 Esplugues de Llobregat (Barcelona) SPAIN

Date of the last revision of this leaflet:May 2013

Detailed and updated information on this medication is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/

Online doctors for ALDOBRONQUIAL 2 mg/5 ml SYRUP

Discuss questions about ALDOBRONQUIAL 2 mg/5 ml SYRUP, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (69)
Doctor

Tarek Agami

General medicine 11 years exp.

Dr. Tarek Agami is a general practitioner registered in both Portugal and Israel, with broad experience in family and preventive medicine. He offers online consultations for adults and children, providing personalised support for primary care needs, chronic disease management, and everyday health concerns.

Dr. Agami received clinical training and worked in leading medical institutions in Israel (Kaplan Medical Center, Barzilai Medical Center, Wolfson Medical Center) and Portugal (European Healthcare City, Viscura Internacional, Hospital Dr. José Maria Grande, Hospital Vila Franca de Xira). His approach combines international medical standards with individualised attention to each patient.

Main areas of consultation:

  • Diagnosis and treatment of acute and chronic conditions (high blood pressure, diabetes, respiratory infections, cardiovascular symptoms)
  • Evaluation of symptoms and guidance on further diagnostic testing
  • Preventive check-ups and regular health monitoring
  • Medical support during travel or after relocation
  • Treatment adjustments and lifestyle recommendations based on your personal history
Dr. Agami provides medical support for patients using GLP-1 medications (such as Ozempic or Mounjaro) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Portugal and Israel.

Dr. Agami is committed to evidence-based, patient-centred care, ensuring that each person receives trusted medical support tailored to their health goals.

Camera Book a video appointment
€69
5.0 (63)
Doctor

Nuno Tavares Lopes

Family medicine 18 years exp.

Dr. Nuno Tavares Lopes is a licensed physician in Portugal with 17 years of experience in emergency medicine, family and general practice, and public health. He is the Director of Medical and Public Health Services at an international healthcare network and serves as an external consultant for the WHO and ECDC.

  • Emergency care: infections, fever, chest/abdominal pain, minor injuries, paediatric emergencies
  • Family medicine: hypertension, diabetes, cholesterol, chronic disease management
  • Travel medicine: pre-travel advice, vaccinations, fit-to-fly certificates, travel-related illnesses
  • Sexual and reproductive health: PrEP, STD prevention, counselling, treatment
  • Weight management and wellness: personalised weight loss programmes, lifestyle guidance
  • Skin and ENT issues: acne, eczema, allergies, rashes, sore throat, sinusitis
  • Pain management: acute and chronic pain, post-surgical care
  • Public health: prevention, health screenings, long-term monitoring
  • Sick leave (Baixa médica) connected to Segurança Social in Portugal
  • IMT medical certificates for driving licence exchange
Dr. Nuno Tavares Lopes provides medical support for patients using GLP-1 medications (Mounjaro, Wegovy, Ozempic, Rybelsus) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Europe.

Dr. Lopes also provides interpretation of medical tests, follow-up care for complex patients, and multilingual support. Whether for urgent concerns or long-term care, he helps patients act with clarity and confidence.

Camera Book a video appointment
€59
5.0 (17)
Doctor

Anastasiia Shalko

Family medicine 13 years exp.

Dr. Anastasiia Shalko is a general practitioner with a background in both paediatrics and general medicine. She graduated from Bogomolets National Medical University in Kyiv and completed her paediatric internship at the P.L. Shupyk National Medical Academy of Postgraduate Education. After working as a paediatrician in Kyiv, she relocated to Spain, where she has been practising general medicine since 2015, providing care for both adults and children.

Her work focuses on urgent, short-term medical concerns – situations where patients need quick guidance, symptom assessment and clear next steps. She helps people understand whether their symptoms require in-person evaluation, home management or a change in treatment. Common reasons for booking an online consultation include:

  • acute respiratory symptoms (cough, sore throat, runny nose, fever)
  • viral illnesses such as colds and seasonal infections
  • gastrointestinal complaints (nausea, diarrhoea, abdominal pain, gastroenteritis)
  • sudden changes in how a child or adult feels
  • questions about existing treatment and whether adjustments are needed
  • renewal of prescriptions when clinically appropriate
Dr. Shalko works specifically with urgent and short-term problems, providing practical recommendations and helping patients determine the safest next step. She explains symptoms clearly, guides patients through decision-making and offers straightforward medical advice for everyday acute issues.

She does not provide long-term management of chronic conditions, ongoing follow-up or comprehensive care plans for complex long-term illnesses. Her consultations are designed for acute symptoms, sudden concerns and situations where timely medical input is important.

With clinical experience in both paediatrics and general medicine, Dr. Shalko confidently supports adults and children. Her communication style is clear, simple and reassuring, helping patients feel informed and supported throughout the consultation.

Camera Book a video appointment
€50
5.0 (3)
Doctor

Tomasz Grzelewski

Dermatology 21 years exp.

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques.

For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance.

Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults.

In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions.

Patients commonly seek his care for:

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns
Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.
Camera Book a video appointment
€80

Frequently Asked Questions

Is a prescription required for ALDOBRONQUIAL 2 mg/5 ml SYRUP?
ALDOBRONQUIAL 2 mg/5 ml SYRUP requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in ALDOBRONQUIAL 2 mg/5 ml SYRUP?
The active ingredient in ALDOBRONQUIAL 2 mg/5 ml SYRUP is salbutamol. This information helps identify medicines with the same composition but different brand names.
How much does ALDOBRONQUIAL 2 mg/5 ml SYRUP cost in pharmacies?
The average pharmacy price for ALDOBRONQUIAL 2 mg/5 ml SYRUP is around 2.06 EUR. Prices may vary depending on the manufacturer and dosage form.
Who manufactures ALDOBRONQUIAL 2 mg/5 ml SYRUP?
ALDOBRONQUIAL 2 mg/5 ml SYRUP is manufactured by Laboratorio Aldo Union S.L.. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of ALDOBRONQUIAL 2 mg/5 ml SYRUP online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether ALDOBRONQUIAL 2 mg/5 ml SYRUP is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to ALDOBRONQUIAL 2 mg/5 ml SYRUP?
Other medicines with the same active substance (salbutamol) include VENTOLIN 0.5 mg/ml INJECTABLE SOLUTION, VENTOLIN 2 mg/5 ml SYRUP, TERBASMIN 0.3 mg/ml ORAL SOLUTION. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media